‘Breakpoint broth microdilution plate’ for susceptibility testing of Gram negative bacilli against colistin sulfate

The MIC method applicable to Gram negative bacilli including Acinetobacter spp. is broth microdilution (BMD). Cost and/or availability issues limit the use of commercial MIC panels in resource limited settings. Objectives: To design and implement an in-house breakpoint BMD panel (BBMD) for colistin...

Full description

Bibliographic Details
Main Authors: Imran Ahmed, Sidra Laiq, Najma Shaheen, Khalid Wahab, Joveria Farooqi, Asima Shahid, Rumina Hasan, Sadia Shakoor
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Practical Laboratory Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352551720301554
id doaj-85530e84a3874baab4679ac39148574b
record_format Article
spelling doaj-85530e84a3874baab4679ac39148574b2020-12-21T04:45:46ZengElsevierPractical Laboratory Medicine2352-55172020-11-0122e00192‘Breakpoint broth microdilution plate’ for susceptibility testing of Gram negative bacilli against colistin sulfateImran Ahmed0Sidra Laiq1Najma Shaheen2Khalid Wahab3Joveria Farooqi4Asima Shahid5Rumina Hasan6Sadia Shakoor7Department of Pathology & Laboratory Medicine, Aga Khan University, PakistanDepartment of Pathology & Laboratory Medicine, Aga Khan University, PakistanDepartment of Pathology & Laboratory Medicine, Aga Khan University, PakistanDepartment of Pathology & Laboratory Medicine, Aga Khan University, PakistanDepartment of Pathology & Laboratory Medicine, Aga Khan University, PakistanDepartment of Pathology & Laboratory Medicine, Aga Khan University, PakistanDepartment of Pathology & Laboratory Medicine, Aga Khan University, PakistanCorresponding author. Stadium Road, Karachi, 74800, Pakistan.; Department of Pathology & Laboratory Medicine, Aga Khan University, PakistanThe MIC method applicable to Gram negative bacilli including Acinetobacter spp. is broth microdilution (BMD). Cost and/or availability issues limit the use of commercial MIC panels in resource limited settings. Objectives: To design and implement an in-house breakpoint BMD panel (BBMD) for colistin against Gram negative bacilli. Design: BBMD panel was prepared in 96-well plate. MIC concentrations of 1, 2, & 4 ​μg/mL for test, and 0.25, 0.5, 1, 2 & 4 ​μg/mL for control strains were selected to accommodate 19 test and 3 quality control strains per plate. Plates were frozen at −80 ​°C until testing. Validation was performed using strains from a previously published study and compared with freshly prepared MIC panel of 16–0.03 ​μg/mL. Results: Validation showed 100% agreement with the reference method and BBMD was introduced into routine laboratory practice for colistin susceptibility of carbapenem resistant Enterobacterales (CRE), Acinetobacter baumannii complex and Pseudomonas aeruginosa. From 2nd July-16th September 2018, a total of 1294 (mean 16.8 ​± ​5.5 isolates/day) clinical isolates were tested; 1157/1294 were reported (MIC ≤2 ​μg/mL) within 24-h, whereas 133 required resistance confirmation by full-range BMD. Resistance was confirmed for all but 24 isolates. These discrepancies were mostly due to contamination with bacterial genera inherently resistant to colistin. Conclusion: This BBMD plate is a high through-put and practical method that could reliably be utilized in a routine microbiology laboratory for colistin susceptibility testing of CRE, A. bauamanii complex and P. aeruginosa.http://www.sciencedirect.com/science/article/pii/S2352551720301554Antimicrobial resistanceColistinMinimum inhibitory concentrationBroth microdilutionBreakpoint susceptibility testing
collection DOAJ
language English
format Article
sources DOAJ
author Imran Ahmed
Sidra Laiq
Najma Shaheen
Khalid Wahab
Joveria Farooqi
Asima Shahid
Rumina Hasan
Sadia Shakoor
spellingShingle Imran Ahmed
Sidra Laiq
Najma Shaheen
Khalid Wahab
Joveria Farooqi
Asima Shahid
Rumina Hasan
Sadia Shakoor
‘Breakpoint broth microdilution plate’ for susceptibility testing of Gram negative bacilli against colistin sulfate
Practical Laboratory Medicine
Antimicrobial resistance
Colistin
Minimum inhibitory concentration
Broth microdilution
Breakpoint susceptibility testing
author_facet Imran Ahmed
Sidra Laiq
Najma Shaheen
Khalid Wahab
Joveria Farooqi
Asima Shahid
Rumina Hasan
Sadia Shakoor
author_sort Imran Ahmed
title ‘Breakpoint broth microdilution plate’ for susceptibility testing of Gram negative bacilli against colistin sulfate
title_short ‘Breakpoint broth microdilution plate’ for susceptibility testing of Gram negative bacilli against colistin sulfate
title_full ‘Breakpoint broth microdilution plate’ for susceptibility testing of Gram negative bacilli against colistin sulfate
title_fullStr ‘Breakpoint broth microdilution plate’ for susceptibility testing of Gram negative bacilli against colistin sulfate
title_full_unstemmed ‘Breakpoint broth microdilution plate’ for susceptibility testing of Gram negative bacilli against colistin sulfate
title_sort ‘breakpoint broth microdilution plate’ for susceptibility testing of gram negative bacilli against colistin sulfate
publisher Elsevier
series Practical Laboratory Medicine
issn 2352-5517
publishDate 2020-11-01
description The MIC method applicable to Gram negative bacilli including Acinetobacter spp. is broth microdilution (BMD). Cost and/or availability issues limit the use of commercial MIC panels in resource limited settings. Objectives: To design and implement an in-house breakpoint BMD panel (BBMD) for colistin against Gram negative bacilli. Design: BBMD panel was prepared in 96-well plate. MIC concentrations of 1, 2, & 4 ​μg/mL for test, and 0.25, 0.5, 1, 2 & 4 ​μg/mL for control strains were selected to accommodate 19 test and 3 quality control strains per plate. Plates were frozen at −80 ​°C until testing. Validation was performed using strains from a previously published study and compared with freshly prepared MIC panel of 16–0.03 ​μg/mL. Results: Validation showed 100% agreement with the reference method and BBMD was introduced into routine laboratory practice for colistin susceptibility of carbapenem resistant Enterobacterales (CRE), Acinetobacter baumannii complex and Pseudomonas aeruginosa. From 2nd July-16th September 2018, a total of 1294 (mean 16.8 ​± ​5.5 isolates/day) clinical isolates were tested; 1157/1294 were reported (MIC ≤2 ​μg/mL) within 24-h, whereas 133 required resistance confirmation by full-range BMD. Resistance was confirmed for all but 24 isolates. These discrepancies were mostly due to contamination with bacterial genera inherently resistant to colistin. Conclusion: This BBMD plate is a high through-put and practical method that could reliably be utilized in a routine microbiology laboratory for colistin susceptibility testing of CRE, A. bauamanii complex and P. aeruginosa.
topic Antimicrobial resistance
Colistin
Minimum inhibitory concentration
Broth microdilution
Breakpoint susceptibility testing
url http://www.sciencedirect.com/science/article/pii/S2352551720301554
work_keys_str_mv AT imranahmed breakpointbrothmicrodilutionplateforsusceptibilitytestingofgramnegativebacilliagainstcolistinsulfate
AT sidralaiq breakpointbrothmicrodilutionplateforsusceptibilitytestingofgramnegativebacilliagainstcolistinsulfate
AT najmashaheen breakpointbrothmicrodilutionplateforsusceptibilitytestingofgramnegativebacilliagainstcolistinsulfate
AT khalidwahab breakpointbrothmicrodilutionplateforsusceptibilitytestingofgramnegativebacilliagainstcolistinsulfate
AT joveriafarooqi breakpointbrothmicrodilutionplateforsusceptibilitytestingofgramnegativebacilliagainstcolistinsulfate
AT asimashahid breakpointbrothmicrodilutionplateforsusceptibilitytestingofgramnegativebacilliagainstcolistinsulfate
AT ruminahasan breakpointbrothmicrodilutionplateforsusceptibilitytestingofgramnegativebacilliagainstcolistinsulfate
AT sadiashakoor breakpointbrothmicrodilutionplateforsusceptibilitytestingofgramnegativebacilliagainstcolistinsulfate
_version_ 1724375700741292032